BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15765031)

  • 1. New therapeutic options for acromegaly.
    Arosio M; Ronchi CL; Epaminonda P; di Lembo S; Adda G
    Minerva Endocrinol; 2004 Dec; 29(4):225-39. PubMed ID: 15765031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acromegaly--do we already know everything about treatment of the somatotroph pituitary adenomas?].
    Zieliński G; Podgórski JK
    Przegl Lek; 2002; 59(7):540-7. PubMed ID: 12516247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for the syndromes of GH excess.
    Arosio M; Cannavò S; Epaminonda P; Ronchi C; Chiodini I; Adda G
    J Endocrinol Invest; 2003; 26(10 Suppl):36-43. PubMed ID: 15497658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of current and emerging treatment options in acromegaly.
    Muhammad A; van der Lely AJ; Neggers SJ
    Neth J Med; 2015 Oct; 73(8):362-7. PubMed ID: 26478545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in the treatment of acromegaly].
    Krysiak R; Okopień B; Marek B
    Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery.
    Yan JL; Chang CN; Chuang CC; Hsu PW; Lin JD; Wei KC; Lee ST; Tseng JK; Pai PC; Chen YL
    J Formos Med Assoc; 2013 Jul; 112(7):416-20. PubMed ID: 23927981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy in acromegaly].
    Góth M; Korbonits M
    Orv Hetil; 2004 Apr; 145(16):867-71. PubMed ID: 15156692
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acromegaly].
    Chanson P
    Presse Med; 2009 Jan; 38(1):92-102. PubMed ID: 19004612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acromegaly.
    Dineen R; Stewart PM; Sherlock M
    QJM; 2017 Jul; 110(7):411-420. PubMed ID: 26873451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient.
    van der Lely AJ; Muller A; Janssen JA; Davis RJ; Zib KA; Scarlett JA; Lamberts SW
    J Clin Endocrinol Metab; 2001 Feb; 86(2):478-81. PubMed ID: 11157994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acromegaly: a review of current medical therapy and new drugs on the horizon.
    Fleseriu M; Delashaw JB; Cook DM
    Neurosurg Focus; 2010 Oct; 29(4):E15. PubMed ID: 20887125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic management of acromegaly].
    Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
    Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy or surgery as primary treatment for acromegaly?
    Ferone D; Colao A; van der Lely AJ; Lamberts SW
    Drugs Aging; 2000 Aug; 17(2):81-92. PubMed ID: 10984197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.